LT-175

N/A

Report date: 2021/12/28 13:57:07
NME

Base Information

Drug NameLT-175
Drug Alias NameLT-175
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α modulatorsPeroxisome proliferator-activated receptor γ modulators
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsHyperlipidemiasDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversità Degli Studi Di Udine
China Registration ClassN/A

Develop Information

Active CompaniesUniversità Degli Studi Di Udine
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A